All lobbying filings

FOLEY HOAG LLP

FOLEY HOAG LLP filed a Q3 termination report for TONIX PHARMACEUTICALS on August 7, 2026, reporting $20,000 in lobbying income.

Lobbying for TONIX PHARMACEUTICALS · Manufacturer of pharmaceutical products.

All filings by FOLEY HOAG LLP · Everything TONIX PHARMACEUTICALS has reported

Filing · LD-2 quarterly report Q3 termination

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Aug 7, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

New York

Representation ended

Jul 31, 2026

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues pertaining to access to non-opioid alternatives

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.